Wockhardt Limited
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
What Wockhardt files
- Others57
- Updates31
- Board Meeting9
- Investor Meet6
- Important4
- PPTs3
1. Business Performance: Wockhardt delivered robust FY26 performance with total income hitting INR 3,373 Cr and EBITDA soaring 51% YoY to INR 630 Cr! PBT reached INR 238 Cr. Profitability improved significantly, with EBITDA margin climbing to 18.6% from 5.4%. Specialty business (novel antibiotics, biosimilars) contributed 23% to revenues, with...
1. Financial Highlights: Wockhardt reported total income of INR 3,033 Cr, up 5% year-over-year, with EBITDA surging 67% to INR 418 Cr. EBITDA margin expanded to 14% from 9%, reflecting strong operational leverage. Net debt-to-equity ratio stands at a low 0.01, with debt reduced by INR 397 Cr to INR...
1. Financial Highlights: Wockhardt posted revenues of INR 3,033 Cr, up 5% YoY. EBITDA surged 67% to INR 418 Cr, lifting margins to 14% from 9%. Net debt decreased by INR 397 Cr to INR 64 Cr, with a net debt-to-equity ratio of 0.01, highlighting a solid balance sheet and...